ACCOLADE INC (ACCD)
US00437E1029 - Common Stock
We assign a fundamental rating of 3 out of 10 to ACCD. ACCD was compared to 118 industry peers in the Health Care Providers & Services industry. The financial health of ACCD is average, but there are quite some concerns on its profitability. ACCD has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
ACCD had negative earnings in the past year.
ACCD had a negative operating cash flow in the past year.
ACCD had negative earnings in each of the past 5 years.
In the past 5 years ACCD always reported negative operating cash flow.
1.2 Ratios
ACCD's Return On Assets of -15.63% is on the low side compared to the rest of the industry. ACCD is outperformed by 75.21% of its industry peers.
ACCD's Return On Equity of -28.23% is in line compared to the rest of the industry. ACCD outperforms 40.17% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -15.63% | ||
| ROE | -28.23% | ||
| ROIC | N/A |
ROA(3y)-23.71%
ROA(5y)-45.45%
ROE(3y)-41.46%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a decent Gross Margin value of 44.81%, ACCD is doing good in the industry, outperforming 75.21% of the companies in the same industry.
In the last couple of years the Gross Margin of ACCD has grown nicely.
ACCD does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 44.81% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.63%
GM growth 5Y8.22%
2. Health
2.1 Basic Checks
ACCD does not have a ROIC to compare to the WACC, probably because it is not profitable.
There is no outstanding debt for ACCD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
Based on the Altman-Z score of -0.72, we must say that ACCD is in the distress zone and has some risk of bankruptcy.
ACCD's Altman-Z score of -0.72 is on the low side compared to the rest of the industry. ACCD is outperformed by 70.94% of its industry peers.
A Debt/Equity ratio of 0.48 indicates that ACCD is not too dependend on debt financing.
ACCD has a Debt to Equity ratio of 0.48. This is in the better half of the industry: ACCD outperforms 61.54% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.48 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -0.72 |
ROIC/WACCN/A
WACC6.24%
2.3 Liquidity
ACCD has a Current Ratio of 2.35. This indicates that ACCD is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of ACCD (2.35) is better than 81.20% of its industry peers.
A Quick Ratio of 2.35 indicates that ACCD has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 2.35, ACCD belongs to the top of the industry, outperforming 83.76% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.35 | ||
| Quick Ratio | 2.35 |
3. Growth
3.1 Past
ACCD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 41.15%, which is quite impressive.
EPS 1Y (TTM)41.15%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q76.19%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Revenue growth Q2Q26.06%
3.2 Future
ACCD is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 23.95% yearly.
The Revenue is expected to grow by 19.14% on average over the next years. This is quite good.
EPS Next Y13.49%
EPS Next 2Y11.73%
EPS Next 3Y29.06%
EPS Next 5Y23.95%
Revenue Next Year18.24%
Revenue Next 2Y18.15%
Revenue Next 3Y18.11%
Revenue Next 5Y19.14%
3.3 Evolution
4. Valuation
4.1 Price/Earnings Ratio
ACCD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ACCD. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
ACCD's earnings are expected to grow with 29.06% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y11.73%
EPS Next 3Y29.06%
5. Dividend
5.1 Amount
ACCD does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
ACCOLADE INC
NASDAQ:ACCD (5/17/2024, 7:00:00 PM)
After market: 7.48 0 (0%)7.48
+0.15 (+2.05%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap586.13M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -15.63% | ||
| ROE | -28.23% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 44.81% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.49
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.48 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 2.35 | ||
| Quick Ratio | 2.35 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)41.15%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y13.49%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y